(Q31037061)

English

Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 October 2017

Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation (English)

1 reference

Europe PubMed Central

16 October 2017

atrial fibrillation

0 references

cost-effectiveness analysis

1 reference

based on heuristic

inferred from title

Deborah Marshall

2

1 reference

Europe PubMed Central

16 October 2017

author name string

Elisabeth Fenwick

1

1 reference

Europe PubMed Central

16 October 2017

Adrian R Levy

3

1 reference

Europe PubMed Central

16 October 2017

Graham Nichol

4

1 reference

Europe PubMed Central

16 October 2017

publication date

19 April 2006

1 reference

Europe PubMed Central

16 October 2017

BMC Health Services Research

1 reference

Europe PubMed Central

16 October 2017

6

1 reference

Europe PubMed Central

16 October 2017

52

1 reference

Europe PubMed Central

16 October 2017

https://scigraph.springernature.com/pub.10.1186/1472-6963-6-52

0 references

Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538588

21 June 2018

An economic evaluation of sequential i.v./po moxifloxacin therapy compared to i.v./po co-amoxiclav with or without clarithromycin in the treatment of community-acquired pneumonia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538588

21 June 2018

Meta-analysis of data on costs from trials of counselling in primary care: using individual patient data to overcome sample size limitations in economic analyses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538588

21 June 2018

Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis. Commentary: evaluating disease modifying treatments in multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538588

21 June 2018

Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538588

21 June 2018

A comparison of rate control and rhythm control in patients with atrial fibrillation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538588

21 June 2018

Multicentre aneurysm screening study (MASS): cost effectiveness analysis of screening for abdominal aortic aneurysms based on four year results from randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538588

21 June 2018

Inference for the cost-effectiveness acceptability curve and cost-effectiveness ratio.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538588

21 June 2018

Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538588

21 June 2018

Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538588

21 June 2018

Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538588

21 June 2018

The CE plane: a graphic representation of cost-effectiveness.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538588

21 June 2018

Cost-effectiveness of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: a decision-making approach

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-6-52

21 January 2018

Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: a randomised controlled trial in primary care

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-6-52

21 January 2018

Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-6-52

21 January 2018

Effect of clinical risk stratification on cost-effectiveness of the implantable cardioverter-defibrillator: the Canadian implantable defibrillator study

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-6-52

21 January 2018

Cost-effectiveness of rhythm versus rate control in atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-6-52

21 January 2018

Representing uncertainty: the role of cost-effectiveness acceptability curves

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-6-52

21 January 2018

Definition, interpretation and calculation of cost-effectiveness acceptability curves.

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-6-52

21 January 2018

Costs, effects and C/E-ratios alongside a clinical trial.

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-6-52

21 January 2018

To be or not to be in normal sinus rhythm: what do we really know?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16623946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An economic evaluation of activated protein C treatment for severe sepsis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16623946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16623946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16623946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane

1 reference

https://pubmed.ncbi.nlm.nih.gov/16623946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Problems with interval estimates of the incremental cost-effectiveness ratio

1 reference

https://pubmed.ncbi.nlm.nih.gov/16623946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Handling uncertainty when performing economic evaluation of healthcare interventions

1 reference

https://pubmed.ncbi.nlm.nih.gov/16623946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1472-6963-6-52

1 reference

Europe PubMed Central

16 October 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

16 October 2017

1 reference

Europe PubMed Central

16 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31037061&oldid=1545962497"